Delivery Order SPE2DB22D3501-SPE2DB24FWC85

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,422.56 firm-fixed-price delivery order is for the supply of 10,000 units of PROCRIT 10,000 units/mL vials. The contract has an ultimate completion date of November 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 30, 2022. The $6,327.14 firm fixed-price delivery order is for the supply of 40,000 units/mL of the drug PROCRIT. The contract has a completion date of December 1, 2022 and is not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award is for the delivery of PROCRIT 40,000 UNITS/ML VIALML to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $4,755.32 and is a Firm Fixed Price Delivery Order. The ultimate completion date is February 26, 2025. This contract award is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,217.72 firm fixed-price delivery order contract is for the provision of 4,000 units/mL of the medication PROCRIT. The award has an ultimate completion date of December 5, 2024 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,306.99, is a firm fixed-price delivery order for 20,000 units of PROCRIT 20,000 UNITS/ML VIALML. The contract has an ultimate completion date of March 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $9,488.38 firm fixed price delivery order is for the supply of 20,000 units of PROCRIT 20,000 units/mL vials. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,200.54, is for the delivery of Procrit (10,000 units/mL vials) to support military healthcare programs. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,464.37 Firm Fixed Price Delivery Order is for the procurement of 10,000 units of the drug Procrit (Epoetin alfa) with a delivery date of February 2, 2023. The award is not associated with a set-aside program and does not mention any subcontractors. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,592.84 firm fixed-price contract is for the delivery of 40,000 units of the medication PROCRIT, a treatment for anemia, to fulfill federal medical supply requirements. The contract has a completion date of June 13, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,991.78 firm-fixed-price delivery order is for the supply of 40,000 units of the drug Procrit (40,000 units/mL) and does not have a set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWC85
    Delivery Order

This federal contract award is for the delivery of 10,000 units of PROCRIT (epoetin alfa) 10,000 units/mL vials to the Defense Logistics Agency (DLA). The $2,087.69 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract does not have a set-aside designation and runs through July 1, 2024.

Amerisourcebergen holds a single-award $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through December 2025 to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense globally. The company also has a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities through May 2024.

Generated 9/27/24, 9:12 AM